Staging of neurofibrillary pathology in Alzheimer's disease: A study of the BrainNet Europe consortium

Irina Alafuzoff, Thomas Arzberger, Safa Al-Sarraj, Istvan Bodi, Nenad Bogdanovic, Heiko Braak, Orso Bugiani, Kelly Del-Tredici, Isidro Ferrer, Ellen Gelpi, Giorgio Giaccone, Manuel B. Graeber, Paul Ince, Wouter Kamphorst, Andrew King, Penelope Korkolopoulou, Gábor G. Kovács, Sergey Larionov, David Meyronet, Camelia MonoranuPiero Parchi, Efstratios Patsouris, Wolfgang Roggendorf, Danielle Seilhean, Fabrizio Tagliavini, Christine Stadelmann, Nathalie Streichenberger, Dietmar R. Thal, Stephen B. Wharton, Hans Kretzschmar

Research output: Contribution to journalArticle

232 Citations (Scopus)

Abstract

It has been recognized that molecular classifications will form the basis for neuropathological diagnostic work in the future. Consequently, in order to reach a diagnosis of Alzheimer's disease (AD), the presence of hyperphosphorylated tau (HP-tau) and β-amyloid protein in brain tissue must be unequivocal. In addition, the stepwise progression of pathology needs to be assessed. This paper deals exclusively with the regional assessment of AD-related HP-tau pathology. The objective was to provide straightforward instructions to aid in the assessment of AD-related immunohistochemically (IHC) detected HP-tau pathology and to test the concordance of assessments made by 25 independent evaluators. The assessment of progression in 7-μm-thick sections was based on assessment of IHC labeled HP-tau immunoreactive neuropil threads (NTs). Our results indicate that good agreement can be reached when the lesions are substantial, i.e., the lesions have reached isocortical structures (stage V-VI absolute agreement 91%), whereas when only mild subtle lesions were present the agreement was poorer (I-II absolute agreement 50%). Thus, in a research setting when the extent of lesions is mild, it is strongly recommended that the assessment of lesions should be carried out by at least two independent observers.

Original languageEnglish
Pages (from-to)484-496
Number of pages13
JournalBrain Pathology
Volume18
Issue number4
DOIs
Publication statusPublished - Oct 2008

Fingerprint

Alzheimer Disease
Pathology
Neuropil Threads
Amyloidogenic Proteins
tau Proteins
Brain
Research

Keywords

  • Alzheimer's disease
  • BrainNet Europe consortium
  • Immunohistochemistry
  • Neurofibrillary pathology
  • Neuropathological diagnosis

ASJC Scopus subject areas

  • Neuroscience(all)
  • Pathology and Forensic Medicine

Cite this

Alafuzoff, I., Arzberger, T., Al-Sarraj, S., Bodi, I., Bogdanovic, N., Braak, H., ... Kretzschmar, H. (2008). Staging of neurofibrillary pathology in Alzheimer's disease: A study of the BrainNet Europe consortium. Brain Pathology, 18(4), 484-496. https://doi.org/10.1111/j.1750-3639.2008.00147.x

Staging of neurofibrillary pathology in Alzheimer's disease : A study of the BrainNet Europe consortium. / Alafuzoff, Irina; Arzberger, Thomas; Al-Sarraj, Safa; Bodi, Istvan; Bogdanovic, Nenad; Braak, Heiko; Bugiani, Orso; Del-Tredici, Kelly; Ferrer, Isidro; Gelpi, Ellen; Giaccone, Giorgio; Graeber, Manuel B.; Ince, Paul; Kamphorst, Wouter; King, Andrew; Korkolopoulou, Penelope; Kovács, Gábor G.; Larionov, Sergey; Meyronet, David; Monoranu, Camelia; Parchi, Piero; Patsouris, Efstratios; Roggendorf, Wolfgang; Seilhean, Danielle; Tagliavini, Fabrizio; Stadelmann, Christine; Streichenberger, Nathalie; Thal, Dietmar R.; Wharton, Stephen B.; Kretzschmar, Hans.

In: Brain Pathology, Vol. 18, No. 4, 10.2008, p. 484-496.

Research output: Contribution to journalArticle

Alafuzoff, I, Arzberger, T, Al-Sarraj, S, Bodi, I, Bogdanovic, N, Braak, H, Bugiani, O, Del-Tredici, K, Ferrer, I, Gelpi, E, Giaccone, G, Graeber, MB, Ince, P, Kamphorst, W, King, A, Korkolopoulou, P, Kovács, GG, Larionov, S, Meyronet, D, Monoranu, C, Parchi, P, Patsouris, E, Roggendorf, W, Seilhean, D, Tagliavini, F, Stadelmann, C, Streichenberger, N, Thal, DR, Wharton, SB & Kretzschmar, H 2008, 'Staging of neurofibrillary pathology in Alzheimer's disease: A study of the BrainNet Europe consortium', Brain Pathology, vol. 18, no. 4, pp. 484-496. https://doi.org/10.1111/j.1750-3639.2008.00147.x
Alafuzoff, Irina ; Arzberger, Thomas ; Al-Sarraj, Safa ; Bodi, Istvan ; Bogdanovic, Nenad ; Braak, Heiko ; Bugiani, Orso ; Del-Tredici, Kelly ; Ferrer, Isidro ; Gelpi, Ellen ; Giaccone, Giorgio ; Graeber, Manuel B. ; Ince, Paul ; Kamphorst, Wouter ; King, Andrew ; Korkolopoulou, Penelope ; Kovács, Gábor G. ; Larionov, Sergey ; Meyronet, David ; Monoranu, Camelia ; Parchi, Piero ; Patsouris, Efstratios ; Roggendorf, Wolfgang ; Seilhean, Danielle ; Tagliavini, Fabrizio ; Stadelmann, Christine ; Streichenberger, Nathalie ; Thal, Dietmar R. ; Wharton, Stephen B. ; Kretzschmar, Hans. / Staging of neurofibrillary pathology in Alzheimer's disease : A study of the BrainNet Europe consortium. In: Brain Pathology. 2008 ; Vol. 18, No. 4. pp. 484-496.
@article{070177f7bae54fdc8b7e5010c028efa1,
title = "Staging of neurofibrillary pathology in Alzheimer's disease: A study of the BrainNet Europe consortium",
abstract = "It has been recognized that molecular classifications will form the basis for neuropathological diagnostic work in the future. Consequently, in order to reach a diagnosis of Alzheimer's disease (AD), the presence of hyperphosphorylated tau (HP-tau) and β-amyloid protein in brain tissue must be unequivocal. In addition, the stepwise progression of pathology needs to be assessed. This paper deals exclusively with the regional assessment of AD-related HP-tau pathology. The objective was to provide straightforward instructions to aid in the assessment of AD-related immunohistochemically (IHC) detected HP-tau pathology and to test the concordance of assessments made by 25 independent evaluators. The assessment of progression in 7-μm-thick sections was based on assessment of IHC labeled HP-tau immunoreactive neuropil threads (NTs). Our results indicate that good agreement can be reached when the lesions are substantial, i.e., the lesions have reached isocortical structures (stage V-VI absolute agreement 91{\%}), whereas when only mild subtle lesions were present the agreement was poorer (I-II absolute agreement 50{\%}). Thus, in a research setting when the extent of lesions is mild, it is strongly recommended that the assessment of lesions should be carried out by at least two independent observers.",
keywords = "Alzheimer's disease, BrainNet Europe consortium, Immunohistochemistry, Neurofibrillary pathology, Neuropathological diagnosis",
author = "Irina Alafuzoff and Thomas Arzberger and Safa Al-Sarraj and Istvan Bodi and Nenad Bogdanovic and Heiko Braak and Orso Bugiani and Kelly Del-Tredici and Isidro Ferrer and Ellen Gelpi and Giorgio Giaccone and Graeber, {Manuel B.} and Paul Ince and Wouter Kamphorst and Andrew King and Penelope Korkolopoulou and Kov{\'a}cs, {G{\'a}bor G.} and Sergey Larionov and David Meyronet and Camelia Monoranu and Piero Parchi and Efstratios Patsouris and Wolfgang Roggendorf and Danielle Seilhean and Fabrizio Tagliavini and Christine Stadelmann and Nathalie Streichenberger and Thal, {Dietmar R.} and Wharton, {Stephen B.} and Hans Kretzschmar",
year = "2008",
month = "10",
doi = "10.1111/j.1750-3639.2008.00147.x",
language = "English",
volume = "18",
pages = "484--496",
journal = "Brain Pathology",
issn = "1015-6305",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Staging of neurofibrillary pathology in Alzheimer's disease

T2 - A study of the BrainNet Europe consortium

AU - Alafuzoff, Irina

AU - Arzberger, Thomas

AU - Al-Sarraj, Safa

AU - Bodi, Istvan

AU - Bogdanovic, Nenad

AU - Braak, Heiko

AU - Bugiani, Orso

AU - Del-Tredici, Kelly

AU - Ferrer, Isidro

AU - Gelpi, Ellen

AU - Giaccone, Giorgio

AU - Graeber, Manuel B.

AU - Ince, Paul

AU - Kamphorst, Wouter

AU - King, Andrew

AU - Korkolopoulou, Penelope

AU - Kovács, Gábor G.

AU - Larionov, Sergey

AU - Meyronet, David

AU - Monoranu, Camelia

AU - Parchi, Piero

AU - Patsouris, Efstratios

AU - Roggendorf, Wolfgang

AU - Seilhean, Danielle

AU - Tagliavini, Fabrizio

AU - Stadelmann, Christine

AU - Streichenberger, Nathalie

AU - Thal, Dietmar R.

AU - Wharton, Stephen B.

AU - Kretzschmar, Hans

PY - 2008/10

Y1 - 2008/10

N2 - It has been recognized that molecular classifications will form the basis for neuropathological diagnostic work in the future. Consequently, in order to reach a diagnosis of Alzheimer's disease (AD), the presence of hyperphosphorylated tau (HP-tau) and β-amyloid protein in brain tissue must be unequivocal. In addition, the stepwise progression of pathology needs to be assessed. This paper deals exclusively with the regional assessment of AD-related HP-tau pathology. The objective was to provide straightforward instructions to aid in the assessment of AD-related immunohistochemically (IHC) detected HP-tau pathology and to test the concordance of assessments made by 25 independent evaluators. The assessment of progression in 7-μm-thick sections was based on assessment of IHC labeled HP-tau immunoreactive neuropil threads (NTs). Our results indicate that good agreement can be reached when the lesions are substantial, i.e., the lesions have reached isocortical structures (stage V-VI absolute agreement 91%), whereas when only mild subtle lesions were present the agreement was poorer (I-II absolute agreement 50%). Thus, in a research setting when the extent of lesions is mild, it is strongly recommended that the assessment of lesions should be carried out by at least two independent observers.

AB - It has been recognized that molecular classifications will form the basis for neuropathological diagnostic work in the future. Consequently, in order to reach a diagnosis of Alzheimer's disease (AD), the presence of hyperphosphorylated tau (HP-tau) and β-amyloid protein in brain tissue must be unequivocal. In addition, the stepwise progression of pathology needs to be assessed. This paper deals exclusively with the regional assessment of AD-related HP-tau pathology. The objective was to provide straightforward instructions to aid in the assessment of AD-related immunohistochemically (IHC) detected HP-tau pathology and to test the concordance of assessments made by 25 independent evaluators. The assessment of progression in 7-μm-thick sections was based on assessment of IHC labeled HP-tau immunoreactive neuropil threads (NTs). Our results indicate that good agreement can be reached when the lesions are substantial, i.e., the lesions have reached isocortical structures (stage V-VI absolute agreement 91%), whereas when only mild subtle lesions were present the agreement was poorer (I-II absolute agreement 50%). Thus, in a research setting when the extent of lesions is mild, it is strongly recommended that the assessment of lesions should be carried out by at least two independent observers.

KW - Alzheimer's disease

KW - BrainNet Europe consortium

KW - Immunohistochemistry

KW - Neurofibrillary pathology

KW - Neuropathological diagnosis

UR - http://www.scopus.com/inward/record.url?scp=47549094635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47549094635&partnerID=8YFLogxK

U2 - 10.1111/j.1750-3639.2008.00147.x

DO - 10.1111/j.1750-3639.2008.00147.x

M3 - Article

C2 - 18371174

AN - SCOPUS:47549094635

VL - 18

SP - 484

EP - 496

JO - Brain Pathology

JF - Brain Pathology

SN - 1015-6305

IS - 4

ER -